CUTISS closes CHF 56M Series C round and signs agreement with leading EU burn center

Funding to support Phase 3 trial of denovoSkin™ and preparation for its commercialization, to advance the automation platform for tissue bioengineering, and to enable the market launch of VitiCell®.Agreement with Rode Kruis Ziekenhuis establishes basis for a future CUTISS production center in The Netherlands.View original content:https://www.prnewswire.co.uk/news-releases/cutiss-closes-chf-56m-series-c-round-and-signs-agreement-with-leading-eu-burn-center-302548028.html